Clinical Trial Update: Stromal Tumor-Infiltrating Lymphocyte Levels Are Associated With Immune Checkpoint Proteins In Triple Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

View source ↗

Summary

This completed clinical trial investigated the relationship between stromal tumor-infiltrating lymphocyte (TIL) levels and immune checkpoint protein expression …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Ziauddin University | Conditions: Triple Negative Breast Cancer | Status: COMPLETED